Clinical Trial 41561


New York, NY 10036

Study Summary:

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously as compared to placebo during maintenance treatment in adult and adolescent patients with schizophrenia.

Qualified Participants Must:

• 13 to 65 years of age (male or female)
• Have a confirmed diagnosis of schizophrenia
• Be clinically stable
• Be eligible for risperidone treatment

Qualified Participants May Receive:

transportation and stipend 

Study is Available At:

Mood Disoders Center
2 West 46th Street, Suite 511
New York, NY 10036
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.